
Amman Ayub is Lead Counsel, UK & Ireland at Advanz Pharma and has over 12 years’ experience advising within the pharmaceutical and medical aesthetics sectors. An early adopter of AI, Amman is particularly interested in how AI can be used pragmatically and responsibly within legal teams, balancing innovation with regulatory and ethical considerations.
.jpg)
Outcome: Leave a strong understanding of how AI solutions may violate the EU AI Act. Critical for those tasked with rolling out global initiatives in EU markets.